Page last updated: 2024-09-05

l 778,123 and methionine

l 778,123 has been researched along with methionine in 1 studies

Compound Research Comparison

Studies (l 778,123)	Trials (l 778,123)	Recent Studies (post-2010) (l 778,123)	Studies (methionine)	Trials (methionine)	Recent Studies (post-2010) (methionine)
23	3	2	27,485	530	5,020

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamilton, AD; Kastens, E; Lantry, LE; Liu, G; Lubet, RA; Sebti, SM; Wang, Y; You, M; Zhang, Z	1

Other Studies

1 other study(ies) available for l 778,123 and methionine

Article	Year
Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf. Oncogene, 2003, Sep-18, Volume: 22, Issue:40 Topics: Adenocarcinoma; Alkyl and Aryl Transferases; Animals; Anticarcinogenic Agents; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Inhibitors; Farnesyltranstransferase; Gene Deletion; Genes, Dominant; Genes, p53; Heterozygote; Imidazoles; Lung Neoplasms; Methionine; Mice; Mice, Inbred A; Mice, Knockout; Mice, Transgenic	2003

Article

Year

Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.

Oncogene, 2003, Sep-18, Volume: 22, Issue:40

Topics: Adenocarcinoma; Alkyl and Aryl Transferases; Animals; Anticarcinogenic Agents; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Inhibitors; Farnesyltranstransferase; Gene Deletion; Genes, Dominant; Genes, p53; Heterozygote; Imidazoles; Lung Neoplasms; Methionine; Mice; Mice, Inbred A; Mice, Knockout; Mice, Transgenic

2003